Eton Pharmaceuticals, Inc. (ETON) Total liabilities 2019–2025
Eton Pharmaceuticals, Inc. (ETON) total liabilities at each fiscal year-end, per SEC filings.
$66.0MFY2025 · since FY2019: $6.5M → $66.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $66.0M | +27.6% |
| FY2024 | $51.7M | +217.9% |
| FY2023 | $16.3M | +36.1% |
| FY2022 | $12.0M | +21.5% |
| FY2021 | $9.8M | -7.7% |
| FY2020 | $10.7M | +63.4% |
| FY2019 | $6.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ETON financial trends
ETON RevenueETON Net incomeETON Net marginETON Gross profitETON Gross marginETON Operating incomeETON Operating marginETON Operating cash flowETON Free cash flowETON Capital expendituresETON Return on equityETON Stock buybacksETON Dividends paidETON Total assetsETON Shareholders’ equityETON overview →